Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CGTX Cognition Therapeutics, Inc

已收盘 05-07 16:00:00 EDT

1.16

-0.07

-5.69%

盘后1.18

+0.02+1.72%

19:58 EDT

最高1.26	最低1.13	成交量94.04万
今开1.24	昨收1.23	日振幅10.57%
总市值1.04亿	流通市值9,574万	总股本8,935万
成交额109.23万	换手率1.14%	流通股本8,253万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CGTX","market":"US","secType":"STK","nameCN":"Cognition Therapeutics, Inc","latestPrice":1.16,"timestamp":1778184000000,"preClose":1.23,"halted":0,"volume":940425,"hourTrading":{"tag":"盘后","latestPrice":1.18,"preClose":1.16,"latestTime":"19:58 EDT","volume":28825,"amount":33537.2569,"timestamp":1778198335894,"change":0.02,"changeRate":0.017241,"amplitude":0.034483},"delay":0,"changeRate":-0.05691056910569111,"floatShares":82532000,"shares":89353773,"eps":-0.32277,"marketStatus":"已收盘","change":-0.07,"latestTime":"05-07 16:00:00 EDT","open":1.24,"high":1.26,"low":1.13,"amount":1092341.5366275,"amplitude":0.105691,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.32277,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1778227200000},"marketStatusCode":5,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":1.23,"preHourTrading":{"tag":"盘前","latestPrice":1.24,"preClose":1.23,"latestTime":"09:25 EDT","volume":14149,"amount":17262.5666844,"timestamp":1778160349484,"change":0.01,"changeRate":0.00813,"amplitude":0.097561},"postHourTrading":{"tag":"盘后","latestPrice":1.18,"preClose":1.16,"latestTime":"19:58 EDT","volume":28825,"amount":33537.2569,"timestamp":1778198335894,"change":0.02,"changeRate":0.017241,"amplitude":0.034483},"volumeRatio":1.209686},"requestUrl":"/m/hq/s/CGTX/wiki","defaultTab":"wiki","newsList":[{"id":"1100851859","title":"Cognition Therapeutics公布2025财年业绩报告并披露临床研发进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1100851859","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100851859?lang=zh_cn&edition=full","pubTime":"2026-03-26 19:31","pubTimestamp":1774524675,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics公司近日正式发布了截至2025年12月31日的年度财务报告，同时向投资者同步了旗下创新药物研发管线的最新临床推进动态。这份综合公告既展示了企业在财务层面的稳健表现，又揭示了其在神经退行性疾病治疗领域的前沿探索。\n通过系统性披露关键财务指标与临床里程碑事件，该公司为市场参与者提供了评估其战略执行效能与未来发展潜力的多维视角。在当前生物科技行业融资环境充满挑战的背景下，这类全面透明的信息披露显得尤为珍贵。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154202708","title":"Cognition Therapeutics扩大Zervimesine（CT1812）治疗路易体痴呆的扩展使用计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1154202708","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154202708?lang=zh_cn&edition=full","pubTime":"2026-02-05 20:32","pubTimestamp":1770294745,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics公司近日宣布，将延长其针对路易体痴呆症的在研药物Zervimesine（CT1812）的扩展使用计划。这一举措旨在为更多符合条件的患者提供早期获取该创新疗法的机会。\n扩展使用计划的延续，体现了公司对满足未竟医疗需求的坚定承诺。Zervimesine作为一款靶向σ-2受体的新型小分子药物，通过调节突触功能，有望改善路易体痴呆患者的认知症状。\n该计划允许尚未参与临床试验的患者，在特定条件下获得实验性治疗。研究人员将继续收集真实世界数据，为后续临床开发提供重要参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608089266","title":"Cognition Therapeutics, Inc.盘中异动 早盘大幅拉升5.05%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608089266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608089266?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:34","pubTimestamp":1770042855,"startTime":"0","endTime":"0","summary":"北京时间2026年02月02日22时34分，Cognition Therapeutics, Inc.股票出现异动，股价快速拉升5.05%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202223415a6cab643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202223415a6cab643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","CGTX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128062319","title":"Cognition Therapeutics完成与FDA就Zervimesine治疗路易体痴呆的C类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1128062319","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128062319?lang=zh_cn&edition=full","pubTime":"2026-01-27 20:31","pubTimestamp":1769517110,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics, Inc宣布，已顺利完成与美国食品药品监督管理局就Zervimesine针对路易体痴呆适应症召开的C类会议。此次会议标志着该药物研发进程中的重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138923920","title":"Cognition Therapeutics与杰富瑞签署公开市场销售协议，计划发售最高达7500万美元的普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1138923920","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138923920?lang=zh_cn&edition=full","pubTime":"2025-12-19 07:31","pubTimestamp":1766100670,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics与杰富瑞签署公开市场销售协议，计划发售最高达7500万美元的普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126989645","title":"Cognition Therapeutics提交Zervimesine（Ct1812）在阿尔茨海默病中第三阶段计划于阿尔茨海默病临床试验会议上","url":"https://stock-news.laohu8.com/highlight/detail?id=1126989645","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126989645?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:32","pubTimestamp":1764592329,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics提交Zervimesine（Ct1812）在阿尔茨海默病中第三阶段计划于阿尔茨海默病临床试验会议上","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186073609","title":"Cognition Therapeutics完成早期阿尔茨海默病Zervimesine（Ct1812）第二阶段研究的招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1186073609","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186073609?lang=zh_cn&edition=full","pubTime":"2025-11-13 20:37","pubTimestamp":1763037431,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics完成早期阿尔茨海默病Zervimesine（Ct1812）第二阶段研究的招募","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517100479","title":"Cognition Therapeutics, Inc.盘中异动 早盘股价大跌8.46%报0.385美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517100479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517100479?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185055,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Cognition Therapeutics, Inc.股票出现波动，股价快速跳水8.46%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223055abe9b05a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223055abe9b05a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514830063","title":"Cognition Therapeutics, Inc.盘中异动 早盘急速跳水5.05%报0.470美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514830063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514830063?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:31","pubTimestamp":1740666664,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，Cognition Therapeutics, Inc.股票出现异动，股价大幅跳水5.05%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722310498950fed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722310498950fed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514894977","title":"Chardan Capital：维持Cognition Therapeutics(CGTX.US)评级，由买入调整至买入评级, 目标价由11.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514894977","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514894977?lang=zh_cn&edition=full","pubTime":"2025-02-27 07:17","pubTimestamp":1740611836,"startTime":"0","endTime":"0","summary":"Chardan Capital：维持Cognition Therapeutics(CGTX.US)评级，由买入调整至买入评级, 目标价由11.00美元调整至11.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27071748414473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856377","title":"Cognition Therapeutics, Inc.盘中异动 早盘股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856377?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:40","pubTimestamp":1740580832,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时40分，Cognition Therapeutics, Inc.股票出现波动，股价大幅拉升5.34%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622403396315115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622403396315115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514130650","title":"Cognition Therapeutics, Inc.盘中异动 股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514130650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514130650?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:22","pubTimestamp":1740496963,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时22分，Cognition Therapeutics, Inc.股票出现波动，股价急速下挫5.48%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252322439892582d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252322439892582d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512865604","title":"Cognition Therapeutics, Inc.盘中异动 早盘快速拉升5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512865604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512865604?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:18","pubTimestamp":1739978334,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时18分，Cognition Therapeutics, Inc.股票出现异动，股价大幅上涨5.93%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231854abd50a7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231854abd50a7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CGTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509928232","title":"Cognition Therapeutics, Inc.盘中异动 股价大涨6.27%报0.667美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509928232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509928232?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:31","pubTimestamp":1738765878,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时31分，Cognition Therapeutics, Inc.股票出现异动，股价急速上涨6.27%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223118abc37d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223118abc37d52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4007","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509667644","title":"Cognition Therapeutics, Inc.盘中异动 急速下挫5.75%报0.628美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509667644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509667644?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:08","pubTimestamp":1738685327,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时08分，Cognition Therapeutics, Inc.股票出现波动，股价急速下挫5.75%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000847abc23b7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000847abc23b7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CGTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508414956","title":"Cognition Therapeutics, Inc.盘中异动 股价大跌8.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508414956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508414956?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593169,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Cognition Therapeutics, Inc.股票出现异动，股价急速下跌8.71%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223249a23809a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223249a23809a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4139","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508899448","title":"Cognition Therapeutics, Inc.盘中异动 大幅下跌5.64%报0.725美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508899448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508899448?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:20","pubTimestamp":1738354816,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时20分，Cognition Therapeutics, Inc.股票出现波动，股价快速下挫5.64%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201042017abbe76ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201042017abbe76ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","CGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507622909","title":"Cognition Therapeutics, Inc.盘中异动 大幅跳水5.09%报0.722美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507622909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507622909?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:11","pubTimestamp":1738249865,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时11分，Cognition Therapeutics, Inc.股票出现异动，股价快速下挫5.09%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231105abbd5408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231105abbd5408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","CGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505846272","title":"Cognition Therapeutics, Inc.盘中异动 快速上涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505846272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505846272?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:52","pubTimestamp":1737471135,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时52分，Cognition Therapeutics, Inc.股票出现异动，股价急速上涨5.59%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225215986e3725&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225215986e3725&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CGTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503284516","title":"Cognition Therapeutics, Inc.盘中异动 快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503284516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503284516?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:35","pubTimestamp":1736951704,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时35分，Cognition Therapeutics, Inc.股票出现波动，股价急速上涨5.03%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223504a222ff59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223504a222ff59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cogrx.com","stockEarnings":[{"period":"1week","weight":0.0424},{"period":"1month","weight":0.4683},{"period":"3month","weight":0.2304},{"period":"6month","weight":-0.259},{"period":"1year","weight":1.9461},{"period":"ytd","weight":-0.0889}],"compareEarnings":[{"period":"1week","weight":0.0313},{"period":"1month","weight":0.1137},{"period":"3month","weight":0.083},{"period":"6month","weight":0.0937},{"period":"1year","weight":0.3132},{"period":"ytd","weight":0.0761}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cognition Therapeutics, Inc.于2007年8月21日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发针对中枢神经系统和视网膜年龄相关性退行性疾病的小分子疗法。其主要候选药物zervimesine是一种口服疗法，旨在通过靶向蛋白寡聚体来保护神经元突触，并已在阿尔茨海默病、路易体痴呆和地图状萎缩的临床试验中进行了评估。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.060065},{"month":2,"riseRate":0,"avgChangeRate":-0.189802},{"month":3,"riseRate":0.2,"avgChangeRate":-0.073136},{"month":4,"riseRate":0.8,"avgChangeRate":0.125839},{"month":5,"riseRate":0.4,"avgChangeRate":-0.069097},{"month":6,"riseRate":0.25,"avgChangeRate":-0.038614},{"month":7,"riseRate":0.25,"avgChangeRate":0.074037},{"month":8,"riseRate":0.5,"avgChangeRate":0.719491},{"month":9,"riseRate":0,"avgChangeRate":-0.232471},{"month":10,"riseRate":0.5,"avgChangeRate":0.012004},{"month":11,"riseRate":0.2,"avgChangeRate":0.100902},{"month":12,"riseRate":0.4,"avgChangeRate":0.102692}],"exchange":"NASDAQ","name":"Cognition Therapeutics, Inc","nameEN":"Cognition Therapeutics, Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cognition Therapeutics, Inc(CGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cognition Therapeutics, Inc,CGTX,Cognition Therapeutics, Inc股票,Cognition Therapeutics, Inc股票老虎,Cognition Therapeutics, Inc股票老虎国际,Cognition Therapeutics, Inc行情,Cognition Therapeutics, Inc股票行情,Cognition Therapeutics, Inc股价,Cognition Therapeutics, Inc股市,Cognition Therapeutics, Inc股票价格,Cognition Therapeutics, Inc股票交易,Cognition Therapeutics, Inc股票购买,Cognition Therapeutics, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cognition Therapeutics, Inc(CGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}